⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28295218 | 1.00 | — | — | |
| SCHEMBL28293444 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28146482 | 0.97 | — | — | |
| SCHEMBL1132268 | 0.76 | — | — | |
| SCHEMBL2036087 | 0.76 | — | — | |
| SCHEMBL24897455 | 0.75 | — | — | |
| SCHEMBL23375976 | 0.75 | — | — | |
| SCHEMBL19513285 | 0.75 | — | — | |
| SCHEMBL9003643 | 0.74 | — | — | |
| SCHEMBL15545927 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100174074-A1 | NOVEL BENZOPHENONE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-08 | — | — | US | claimed |
| EP-2142506-A1 | NOVEL BENZOPHENONE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | Council of Scientific&Industrial Research (IN) | 2010-01-13 | — | — | EP | claimed |
| WO-2008120235-A1 | NOVEL BENZOPHENONE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2008-10-09 | — | — | WO | claimed |
| US-20220144759-A1 | COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| CN-108419435-A | Compound and epigenetics for treating cancer | 新加坡科技研究局 | 2018-08-17 | — | — | CN | disclosed |
| EP-3312178-A1 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Inc. (US) | 2018-04-25 | — | — | EP | disclosed |
| WO-2017101890-A1 | SPIROKETAL DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION | 上海艾力斯医药科技有限公司 | 2017-06-22 | — | — | WO | disclosed |
| CN-103764658-B | Compound, its pharmaceutical composition and its purposes as the IDH1 mutant inhibitor for treating cancer | 安吉奥斯医药品有限公司 | 2017-06-09 | — | — | CN | disclosed |
| CN-106573928-A | 2-aminothiazole derivative or salt thereof | 安斯泰来制药株式会社 | 2017-04-19 | — | — | CN | disclosed |
| CN-103080269-B | Photochromic composition | TOKUYAMA CORP. (JP) | 2015-12-16 | — | — | CN | disclosed |
| CN-103265677-A | Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound | TOSOH CORP | 2013-08-28 | — | — | CN | disclosed |
| US-4092318-A | HYPOTENSIVES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-30 | — | — | US | disclosed |
| US-4082773-A | TRICYCLIC TETRAHYDRO NAPHTHALENEOLS AND RELATED COMPOUNDS | E. R. SQUIBB & SONS, INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4053596-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1977-10-11 | — | — | US | disclosed |
| US-4044040-A | HYPERTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1977-08-23 | — | — | US | disclosed |
| US-3984419-A | HYPOTENSIVES | E. R. SQUIBB & SONS, INC. (US) | 1976-10-05 | — | — | US | disclosed |
| US-3982021-A | Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols | E. R. SQUIBB & SONS, INC. (US) | 1976-09-21 | — | — | US | disclosed |
| US-3951950-A | ANTIVIRAL, CARDIOVASCULAR, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-04-20 | — | — | US | disclosed |
| US-3943149-A | HYPOCHOLESTEREMIC, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-03-09 | — | — | US | disclosed |
| US-3935267-A | CARDIOVASCULAR DISORDERS | E. R. SQUIBB & SONS, INC. (US) | 1976-01-27 | — | — | US | disclosed |